GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinuvel Pharmaceuticals Ltd (OTCPK:CLVLF) » Definitions » Dividend Yield %

CLVLF (Clinuvel Pharmaceuticals) Dividend Yield % : 0.40% (As of Dec. 12, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Clinuvel Pharmaceuticals Dividend Yield %?

As of today (2024-12-12), the Trailing Annual Dividend Yield of Clinuvel Pharmaceuticals is 0.40%.

Good Sign:

Clinuvel Pharmaceuticals Ltd stock dividend yield is close to 10-year high.

The historical rank and industry rank for Clinuvel Pharmaceuticals's Dividend Yield % or its related term are showing as below:

CLVLF' s Dividend Yield % Range Over the Past 10 Years
Min: 0.05   Med: 0.12   Max: 0.4
Current: 0.4

During the past 13 years, the highest Dividend Yield of Clinuvel Pharmaceuticals was 0.40%. The lowest was 0.05%. And the median was 0.12%.

CLVLF's Dividend Yield % is ranked worse than
85.53% of 159 companies
in the Biotechnology industry
Industry Median: 1.41 vs CLVLF: 0.40

Clinuvel Pharmaceuticals's Dividend Payout Ratio for the six months ended in Jun. 2024 was 0.00.

During the past 13 years, the highest Dividend Payout Ratio of Clinuvel Pharmaceuticals was 0.08. The lowest was 0.05. And the median was 0.07.

As of today (2024-12-12), the Forward Dividend Yield % of Clinuvel Pharmaceuticals is 0.40%.

Clinuvel Pharmaceuticals's Dividends per Share for the six months ended in Jun. 2024 was $0.00.

During the past 12 months, Clinuvel Pharmaceuticals's average Dividends Per Share Growth Rate was 25.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 26.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 18.70% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Clinuvel Pharmaceuticals was 26.00% per year. The lowest was 7.70% per year. And the median was 17.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Clinuvel Pharmaceuticals Dividend Yield % Historical Data

The historical data trend for Clinuvel Pharmaceuticals's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinuvel Pharmaceuticals Dividend Yield % Chart

Clinuvel Pharmaceuticals Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.09 0.19 0.22 0.32

Clinuvel Pharmaceuticals Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.19 0.22 0.31 0.32

Competitive Comparison of Clinuvel Pharmaceuticals's Dividend Yield %

For the Biotechnology subindustry, Clinuvel Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinuvel Pharmaceuticals's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clinuvel Pharmaceuticals's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Clinuvel Pharmaceuticals's Dividend Yield % falls into.



Clinuvel Pharmaceuticals Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Clinuvel Pharmaceuticals Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
AUD 0.0500002024-09-052024-09-062024-09-20Cash DividendannuallyAUD:USD 0.665779

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Clinuvel Pharmaceuticals's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.03328895/8.45
=0.39 %

Current Share Price is $8.45.
Clinuvel Pharmaceuticals's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.03328895.

Clinuvel Pharmaceuticals's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.03328895/8.45
=0.39 %

Current Share Price is $8.45.
Clinuvel Pharmaceuticals's Dividends per Share for the forward twelve months is calculated as $0.03328895 * 1 = $0.03328895.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clinuvel Pharmaceuticals  (OTCPK:CLVLF) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Clinuvel Pharmaceuticals Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Clinuvel Pharmaceuticals's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clinuvel Pharmaceuticals Business Description

Address
535 Bourke Street, Level 22, Melbourne, VIC, AUS, 3000
Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.

Clinuvel Pharmaceuticals Headlines

From GuruFocus

CLINUVEL progresses innovative DNA Repair Program

By Marketwired Marketwired 09-10-2020

CLINUVEL progresses vitiligo treatment program

By GuruFocusNews GuruFocusNews 05-10-2022

CLINUVEL progresses vitiligo treatment program

By GuruFocusNews GuruFocusNews 07-09-2022

CLINUVEL progresses vitiligo treatment program

By GuruFocusNews GuruFocusNews 06-19-2022

CLINUVEL progresses vitiligo treatment program

By GuruFocusNews GuruFocusNews 05-30-2022

SCENESSE® to be Prescribed in China

By Marketwired Marketwired 04-23-2020